Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats
Authors:
- 1 June 2011
- journal article
- Published by Elsevier in Brain Research
- Vol. 1398, 94-101
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30570976)
This publication has 32 references indexed in Scilit:
- PACAP and VIP prevent apoptosis in schwannoma cellsBrain Research, 2008
- Influence of Hyperglycemia on Oxidative Stress and Matrix Metalloproteinase-9 Activation After Focal Cerebral Ischemia/Reperfusion in RatsStroke, 2007
- Arundic Acid (ONO-2506) Ameliorates Delayed Ischemic Brain Damage by Preventing Astrocytic Overproduction of S100BCNS & Neurological Disorders - Drug Targets, 2005
- Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activationThe FASEB Journal, 2003
- Vasoactive intestinal peptide attenuates cytochrome c translocation, and apoptosis, in rat hippocampal stem cellsNeuroscience Letters, 2002
- Comparison of serum S-100 protein levels following stroke and traumatic brain injuryJournal of the Neurological Sciences, 2000
- Chemokines Released from Astroglia by Vasoactive Intestinal Peptide: Mechanism of Neuroprotection from HIV Envelope Protein ToxicityAnnals of the New York Academy of Sciences, 2000
- S100β Induces Neuronal Cell Death Through Nitric Oxide Release from AstrocytesJournal of Neurochemistry, 1997
- Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the ratBrain Research, 1990
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986